Diethrich E B, Bahadir I, Gordon M, Maki P, Warner M G, Clark R, Siever J, Silverthorn A
J Thorac Cardiovasc Surg. 1987 Sep;94(3):389-92.
Heart-lung transplantation for treatment of end-stage cardiopulmonary disease continues to be plagued by many problems. Three primary ones are the technical difficulties that can be encountered, particularly in those patients who have undergone previous cardiac operations, the additional restriction on donor availability imposed by the lack of satisfactory preservation techniques, and the need for lung size compatibility. Two of these difficulties and others surfaced postoperatively in a heart-lung transplant recipient who presented a series of unique operative and therapeutic challenges. A 42-year-old woman with chronic pulmonary hypertension and previous atrial septal defect repair underwent a heart-lung transplantation in August 1985. The operative procedure was expectedly complicated by bleeding from extensive mediastinal adhesions from the previous sternotomy and bronchial collateralization. Excessive chest tube drainage postoperatively necessitated reoperation to control bleeding from a right bronchial artery tributary. Phrenic nerve paresis, hepatomegaly, and marked abdominal distention caused persistent atelectasis and eventual right lower lobe collapse. Arteriovenous shunting and low oxygen saturation necessitated right lower lobectomy 15 days after transplantation, believed to be the first use of this procedure in a heart-lung graft recipient. Although oxygenation improved dramatically, continued ventilatory support led to tracheostomy. An intensive, psychologically oriented physical therapy program was initiated to access and retrain intercostal and accessory muscles. The tracheostomy cannula was removed after 43 days and gradual weaning from supplemental oxygen was accomplished. During this protracted recovery period, an episode of rejection was also encountered and successfully managed with steroid therapy. The patient continued to progress satisfactorily and was discharged 83 days after transplantation. She is well and active 20 months after discharge.
心肺移植用于治疗终末期心肺疾病仍然受到许多问题的困扰。主要有三个问题,一是可能遇到的技术难题,尤其是在那些先前接受过心脏手术的患者中;二是由于缺乏令人满意的保存技术,供体可用性受到额外限制;三是需要肺大小匹配。其中两个难题以及其他问题在一名心肺移植受者术后出现,该受者带来了一系列独特的手术和治疗挑战。一名42岁患有慢性肺动脉高压且先前接受过房间隔缺损修复术的女性于1985年8月接受了心肺移植。手术过程因先前胸骨切开术导致的广泛纵隔粘连出血和支气管侧支循环而预期变得复杂。术后胸腔引流管引流量过多,需要再次手术以控制右支气管动脉分支出血。膈神经麻痹、肝肿大和明显的腹胀导致持续肺不张并最终右肺下叶塌陷。动静脉分流和低氧饱和度使得在移植后15天进行了右肺下叶切除术,据信这是该手术在心肺移植受者中的首次应用。尽管氧合显著改善,但持续的通气支持导致了气管切开术。启动了一项强化的、以心理为导向的物理治疗计划,以评估和重新训练肋间肌和辅助肌。43天后拔除气管切开套管,并逐步完成了从补充氧气的撤机过程。在这个漫长的恢复期,还出现了一次排斥反应,并通过类固醇治疗成功处理。患者继续顺利康复,并在移植后83天出院。出院20个月后,她身体健康且活动自如。